Quality of life in hemophilia complicated by inhibitors.
作者信息
Bastani P, Pourmohamadi K, Karimi M
机构信息
Student of Health Services Management, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Iran Red Crescent Med J. 2012 Apr;14(4):250-1. Epub 2012 Apr 1.
Abstract
摘要
相似文献
1
Quality of life in hemophilia complicated by inhibitors.合并抑制物的血友病患者的生活质量
Iran Red Crescent Med J. 2012 Apr;14(4):250-1. Epub 2012 Apr 1.
2
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group.血友病合并抑制物患者的护理成本与生活质量：COCIS研究组
Blood. 2003 Oct 1;102(7):2358-63. doi: 10.1182/blood-2003-03-0941. Epub 2003 Jun 19.
3
Health-Related Quality of Life and Psychological Aspects of Adults With Hemophilia in Iran.伊朗成年血友病患者的健康相关生活质量及心理状况
Clin Appl Thromb Hemost. 2018 Oct;24(7):1073-1081. doi: 10.1177/1076029618758954. Epub 2018 Mar 26.
4
Is the Detection of Factor IX Inhibitors in Hemophilia B Orphan than Factor VIII Inhibitors in Hemophilia A? A Concise, Systematic Review.乙型血友病患者中因子 IX 抑制剂的检测是否比甲型血友病患者中因子 VIII 抑制剂的检测更罕见？简明系统评价。
Cardiovasc Hematol Disord Drug Targets. 2020;20(3):185-190. doi: 10.2174/1871529X20666200701104143.
5
Health-related quality of life in Iranian adult men with severe hemophilia.患有严重血友病的伊朗成年男性的健康相关生活质量
Blood Coagul Fibrinolysis. 2017 Dec;28(8):638-641. doi: 10.1097/MBC.0000000000000652.
6
The socioeconomic burden of patients affected by hemophilia with inhibitors.患有血友病抑制剂患者的社会经济负担。
Eur J Haematol. 2018 Oct;101(4):435-456. doi: 10.1111/ejh.13108. Epub 2018 Jul 27.
7
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.重组活化凝血因子 VII 用于高滴度抑制物血友病患者重度膝关节手术及晚期膝关节炎的经济学评价：基于文献建模的探索性结果
Curr Med Res Opin. 2008 Mar;24(3):753-68. doi: 10.1185/030079908X273048. Epub 2008 Jan 29.
8
Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran.
Hematology. 2006 Jun;11(3):215-7. doi: 10.1080/10245330600667526.
9
Modified Primary Prophylaxis in Previously Untreated Patients With Severe Hemophilia A in Iran.
J Pediatr Hematol Oncol. 2018 Apr;40(3):188-191. doi: 10.1097/MPH.0000000000001082.
10
HLA-DRB1*01:01, but not HLA-DRB1:1503 or HLA-DRB1*11, is associated with decreased inhibitor risk in Iranian hemophilia A patients.HLA-DRB1*01:01与伊朗甲型血友病患者中抑制剂风险降低相关，而HLA-DRB1:1503或HLA-DRB1*11则不然。
Transfus Apher Sci. 2019 Oct;58(5):669-673. doi: 10.1016/j.transci.2019.08.019. Epub 2019 Sep 16.
引用本文的文献
1
The impact of inhibitors on the quality of life in patients with hemophilia.抑制剂对血友病患者生活质量的影响。
SAGE Open Med. 2023 Jul 10;11:20503121231182284. doi: 10.1177/20503121231182284. eCollection 2023.
2
Health-Related Quality of Life and Psychological Aspects of Adults With Hemophilia in Iran.伊朗成年血友病患者的健康相关生活质量及心理状况
Clin Appl Thromb Hemost. 2018 Oct;24(7):1073-1081. doi: 10.1177/1076029618758954. Epub 2018 Mar 26.
3
Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study.生活质量、疼痛及自我报告的关节炎与年龄、就业、出血率以及血友病治疗中心和医疗服务提供者服务利用情况之间的关联：HERO研究中成年血友病患者的结果
Patient Prefer Adherence. 2015 Oct 29;9:1549-60. doi: 10.2147/PPA.S87659. eCollection 2015.
本文引用的文献
1
Health status and health-related quality of life associated with hemophilia.与血友病相关的健康状况及健康相关生活质量
Am J Hematol. 2002 Nov;71(3):152-60. doi: 10.1002/ajh.10191.
2
State of care for hemophilia in pediatric patients.小儿血友病患者的护理状况。
Paediatr Drugs. 2002;4(3):149-57. doi: 10.2165/00128072-200204030-00002.
3
Hemophilia. Strategies for the treatment of inhibitor patients.血友病。抑制物患者的治疗策略。
Haematologica. 2000 Oct;85(10 Suppl):15-20.
4
Hemophilia. Treatment of patients with inhibitors: cost issues.血友病。抑制剂患者的治疗：成本问题。
Haemophilia. 1999 Nov;5(6):397-401. doi: 10.1046/j.1365-2516.1999.00368.x.
5
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.10个国家中使用标准算法和特定国家算法估算的SF-36健康概况评分的等效性：IQOLA项目的结果。国际生活质量评估。
J Clin Epidemiol. 1998 Nov;51(11):1167-70. doi: 10.1016/s0895-4356(98)00108-5.
6
Epidemiology of inhibitors in haemophilia A.甲型血友病中抑制物的流行病学
Vox Sang. 1996;70 Suppl 1:2-8.
7
8
Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group.
Transfusion. 1990 Sep;30(7):626-30. doi: 10.1046/j.1537-2995.1990.30790385521.x.
9
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.医学结局研究36项简明健康调查（SF-36）。I.概念框架与条目选择。
Med Care. 1992 Jun;30(6):473-83.
Zotero 插件